Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies.

MLA

Hiroko Fukushima, et al. “Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies.” Leukemia Research & Treatment, Jan. 2013, pp. 1–9. EBSCOhost, https://doi.org/10.1155/2013/238528.

APA

Hiroko Fukushima, Takashi Fukushima, Aiko Sakai, Ryoko Suzuki, Nakajima-Yamaguchi, R., Chie Kobayashi, Atsushi Iwabuchi, Makoto Saito, Ai Yoshimi, Tomohei Nakao, Keisuke Kato, Masahiro Tsuchida, Hideto Takahashi, Kazutoshi Koike, Nobutaka Kiyokawa, Emiko Noguchi, & Ryo Sumazaki. (2013). Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies. Leukemia Research & Treatment, 1–9. https://doi.org/10.1155/2013/238528

Chicago

Hiroko Fukushima, Takashi Fukushima, Aiko Sakai, Ryoko Suzuki, Ryoko Nakajima-Yamaguchi, Chie Kobayashi, Atsushi Iwabuchi, et al. 2013. “Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies.” Leukemia Research & Treatment, January, 1–9. doi:10.1155/2013/238528.